We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.41B
AUM Growth
+$140M
Cap. Flow
+$151M
Cap. Flow %
10.75%
Top 10 Hldgs %
8.08%
Holding
2,051
New
446
Increased
504
Reduced
559
Closed
528

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.69M
2
C icon
Citigroup
C
+$6.01M
3
TRIP icon
TripAdvisor
TRIP
+$5.94M
4
VPHM
VIROPHARMA INC
VPHM
+$5.33M
5
WELL icon
Welltower
WELL
+$5.33M

Sector Composition

Rank Sector Weight
1 Healthcare 15.61%
2 Technology 11.5%
3 Industrials 10.6%
4 Consumer Discretionary 10.6%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
26
Viatris
VTRS
$20.8B
$6.2M 0.44%
126,936
+64,241
+102% +$3.12M
TMO icon
27
Thermo Fisher Scientific
TMO
$214B
$6.18M 0.44%
+51,403
New +$6.11M
TWTR
28
DELISTED
Twitter, Inc.
TWTR
$6.1M 0.43%
+130,629
New +$7.39M
ESRX
29
DELISTED
Express Scripts Holding Company
ESRX
$5.87M 0.42%
78,149
+71,112
+1,011% +$5.33M
BMY icon
30
Bristol-Myers Squibb
BMY
$129B
$5.85M 0.42%
112,677
+103,945
+1,190% +$5.53M
CA
31
DELISTED
CA, Inc.
CA
$5.75M 0.41%
185,600
+159,342
+607% +$5.19M
BKNG icon
32
Booking.com
BKNG
$156B
$5.71M 0.41%
119,775
+51,200
+75% +$2.53M
JCI icon
33
Johnson Controls International
JCI
$85.1B
$5.54M 0.39%
111,699
+90,612
+430% +$4.59M
FDO
34
DELISTED
FAMILY DOLLAR STORES
FDO
$5.45M 0.39%
93,966
+64,814
+222% +$4.09M
PRGO icon
35
Perrigo
PRGO
$1.44B
$5.45M 0.39%
35,213
+20,189
+134% +$3.19M
PRU icon
36
Prudential Financial
PRU
$42.6B
$5.43M 0.39%
64,195
+54,368
+553% +$4.68M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$123B
$5.41M 0.39%
+76,548
New +$6.06M
CNP icon
38
CenterPoint Energy
CNP
$28.3B
$5.36M 0.38%
226,387
+187,557
+483% +$4.41M
NKE icon
39
Nike
NKE
$64.1B
$5.28M 0.38%
142,888
+127,934
+856% +$4.83M
ED icon
40
Consolidated Edison
ED
$41.4B
$5.24M 0.37%
+97,749
New +$5.3M
TT icon
41
Trane Technologies
TT
$98.8B
$5.18M 0.37%
+90,586
New +$5.4M
AGN
42
DELISTED
Allergan Inc
AGN
$5.18M 0.37%
+41,722
New +$5.08M
WMB icon
43
Williams Companies
WMB
$85.8B
$5.13M 0.36%
+126,403
New +$5.12M
FDX icon
44
FedEx
FDX
$73B
$5.05M 0.36%
38,074
+29,421
+340% +$4M
ZBH icon
45
Zimmer Biomet
ZBH
$18.8B
$4.84M 0.34%
52,736
+40,453
+329% +$3.73M
HON icon
46
Honeywell
HON
$76.4B
$4.68M 0.33%
56,210
+48,511
+630% +$4.02M
WFM
47
DELISTED
Whole Foods Market Inc
WFM
$4.47M 0.32%
88,080
+49,319
+127% +$2.63M
TIF
48
DELISTED
Tiffany & Co.
TIF
$4.42M 0.31%
51,349
+48,003
+1,435% +$4.26M
TSLA icon
49
Tesla
TSLA
$1.18T
$4.41M 0.31%
317,010
+295,515
+1,375% +$3.96M
ILMN icon
50
Illumina
ILMN
$29.5B
$4.33M 0.31%
29,919
+26,272
+720% +$3.86M

Similar funds

GSA Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, GSA Capital Partners held 2,051 positions worth $1.41B, up 11% from $1.27B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

GSA Capital Partners deployed $151M of net new capital in Q1 2014, opening 446 new positions and adding to 504 existing holdings. Its largest new stake was Alphabet (Google) Class C: 527,450 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Citigroup, an estimated $6.01M trimmed.

  • GSA Capital Partners's largest Q1 2014 buy was Alphabet (Google) Class C: 527,450 shares worth $14.6M.
  • GSA Capital Partners added most to Micron Technology in Q1 2014, an estimated $12.3M increase.
  • GSA Capital Partners's biggest Q1 2014 reduction was Citigroup, cutting an estimated $6.01M.
  • GSA Capital Partners fully exited Pfizer in Q1 2014, selling an estimated $6.69M.
  • GSA Capital Partners's ten largest holdings make up 8.1% of its $1.41B portfolio in Q1 2014.
  • GSA Capital Partners opened 446 new positions and closed 528 in Q1 2014.
  • GSA Capital Partners's portfolio value rose 11% quarter-over-quarter to $1.41B.

Based on GSA Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.